Who owns Milestone Pharmaceuticals Inc?
- Ticker: MIST
- CUSIP Number: 59935v107
Tip: Access positions for across all investors
Analyze quarterly positions in Milestone Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Milestone Pharmaceuticals stock
Who bought or sold Milestone Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Propel Bio Management | 4.1M | $5.1M | 0% | Mar 2026 |
|
| Adage Capital Partners GP | 2.8M | $5.7M | -60% | Dec 2025 |
|
| Rtw Investments | 2.5M | $5.1M | 0% | Dec 2025 |
|
| Two Sigma Investments | 2.3M | $2.8M | 53% | Mar 2026 |
|
| Goldman Sachs Group | 2.0M | $2.4M | 100% | Mar 2026 |
|
| Marshall Wace | 1.7M | $3.3M | 290% | Dec 2025 |
|
| Millennium Management | 1.5M | $1.8M | 284% | Mar 2026 |
|
| Simplify Asset Management | 1.5M | $1.8M | 0% | Mar 2026 |
|
| Susquehanna International | 1.2M | $2.5M | 129% | Dec 2025 |
|
| Point72 Asset Management | 1.1M | $1.3M | 125% | Mar 2026 |
|
| Balyasny Asset Management | 851k | $1.0M | 100% | Mar 2026 |
|
| Lion Point Capital | 820k | $976k | 9% | Mar 2026 |
|
| Toronto-Dominion Bank | 750k | $893k | 0% | Mar 2026 |
|
| Morgan Stanley | 724k | $862k | -7% | Mar 2026 |
|
| Boxer Capital Management | 667k | $1.3M | 0% | Dec 2025 |
|
| Stonepine Capital Management | 663k | $1.3M | 100% | Dec 2025 |
|
| UBS Group | 495k | $589k | 1% | Mar 2026 |
|
| Citadel Advisors | 347k | $413k | -46% | Mar 2026 |
|
| Squarepoint Ops | 337k | $401k | 35% | Mar 2026 |
|
| Seven Fleet Capital Management | 333k | $397k | 100% | Mar 2026 |
|
| Aptus Capital Advisors | 280k | $334k | 6% | Mar 2026 |
|
| Guardian Wealth Advisors, Llc / Nc | 263k | $532k | 25% | Dec 2025 |
|
| Jane Street | 201k | $239k | -83% | Mar 2026 |
|
| LPL Financial | 193k | $230k | 36% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 177k | $210k | -20% | Mar 2026 |
|
| XTX Topco | 172k | $347k | -8% | Dec 2025 |
|
| Boothbay Fund Management | 169k | $201k | 100% | Mar 2026 |
|
| Valeo Financial Advisors | 131k | $156k | 0% | Mar 2026 |
|
| Group One Trading | 130k | $154k | -33% | Mar 2026 |
|
| Tru Independence Asset Management 2 | 100k | $119k | 0% | Mar 2026 |
|
| ADAR1 Capital Management | 100k | $119k | 0% | Mar 2026 |
|
| Cascades Capital Asset Management | 78k | $157k | 0% | Dec 2025 |
|
| Hrt Financial | 62k | $74k | 100% | Mar 2026 |
|
| Cambridge Investment Research Advisors | 60k | $71k | 26% | Mar 2026 |
|
| Engineers Gate Manager | 59k | $119k | 100% | Dec 2025 |
|
| October Effect | 52k | $62k | 0% | Mar 2026 |
|
| SG Americas Securities | 43k | $51k | -56% | Mar 2026 |
|
| Invesco | 41k | $49k | 89% | Mar 2026 |
|
| Geode Capital Management | 41k | $49k | -45% | Mar 2026 |
|
| Northern Trust | 39k | $79k | 0% | Dec 2025 |
|
| Colony | 36k | $73k | 0% | Dec 2025 |
|
| Qube Research & Technologies | 35k | $70k | 100% | Dec 2025 |
|
| Mariner Wealth Advisors | 31k | $37k | 23% | Mar 2026 |
|
| Bay Rivers Group | 30k | $36k | 4% | Mar 2026 |
|
| Federation des caisses Desjardins du Quebec | 30k | $35k | 0% | Mar 2026 |
|
| GSA Capital Partners | 27k | $32k | -89% | Mar 2026 |
|
| Raymond James Financial | 27k | $54k | 0% | Dec 2025 |
|
| Safeguard Investment Advisory Group | 25k | $30k | 0% | Mar 2026 |
|
| Welch & Forbes | 25k | $30k | 100% | Mar 2026 |
|
| State Street Corporation | 22k | $44k | -2% | Dec 2025 |
|
| Acadian Asset Management | 21k | $24k | -88% | Mar 2026 |
|
| Journey Strategic Wealth | 20k | $24k | -33% | Mar 2026 |
|
| Stephenson & Company | 20k | $24k | 0% | Mar 2026 |
|
| National Bank Of Canada /fi/ | 19k | $38k | 0% | Dec 2025 |
|
| Pathstone Holdings | 17k | $20k | -98% | Mar 2026 |
|
| Jones Financial Companies, L.L | 16k | $32k | 45% | Dec 2025 |
|
| SJS Investment Consulting | 15k | $18k | 0% | Mar 2026 |
|
| Vision Retirement | 15k | $18k | 100% | Mar 2026 |
|
| Exit Wealth Advisors | 15k | $18k | 100% | Mar 2026 |
|
| AE Wealth Management | 15k | $18k | 100% | Mar 2026 |
|
| Taylor Financial Group | 15k | $18k | 50% | Mar 2026 |
|
| Capital Performance Advisors | 15k | $18k | 100% | Mar 2026 |
|
| Cetera Investment Advisers | 15k | $18k | -29% | Mar 2026 |
|
| Beta Wealth | 14k | $17k | 0% | Mar 2026 |
|
| Strategic Family Wealth Counselors | 14k | $17k | 9% | Mar 2026 |
|
| Creative Planning | 13k | $16k | -43% | Mar 2026 |
|
| Rockefeller Capital Management | 13k | $15k | 635% | Mar 2026 |
|
| IMC-Chicago | 11k | $13k | 100% | Mar 2026 |
|
| Sontag Advisory | 11k | $13k | 100% | Mar 2026 |
|
| Bronte Capital Management Pty | 10k | $12k | 0% | Mar 2026 |
|
| Eaton Financial Holdings Company | 10k | $12k | -20% | Mar 2026 |
|
| Bayesian Capital Management | 10k | $12k | -42% | Mar 2026 |
|
| Secure Asset Management | 10k | $12k | 0% | Mar 2026 |
|
| Integral Investment Advisors | 10k | $12k | 0% | Mar 2026 |
|
| HighTower Advisors | 10k | $12k | 100% | Mar 2026 |
|
| Ancora Advisors | 10k | $12k | 0% | Mar 2026 |
|
| Tower Research Capital | 9.0k | $18k | 100% | Dec 2025 |
|
| Royal Bank of Canada | 6.7k | $8.3k | -95% | Mar 2026 |
|
| Us Bancorp | 3.2k | $6.5k | 0% | Dec 2025 |
|
| Caitong International Asset Management | 1.7k | $2.1k | 100% | Mar 2026 |
|
| Pnc Financial Services | 1.0k | $1.2k | 100% | Mar 2026 |
|
| Medallion Wealth Advisors | 340.00 | $405.008000 | 0% | Mar 2026 |
|
| Rialto Wealth Management | 300.00 | $606.000000 | 100% | Dec 2025 |
|
| Key Capital Management | 212.00 | $252.004400 | 0% | Mar 2026 |
|
| Russell Investments | 125.00 | $149.000000 | 100% | Mar 2026 |
|
| SBI Securities | 11.00 | $12.999800 | 83% | Mar 2026 |
|
Who sold out of Milestone Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Affinity Asset Advisors | Sep 2025 | 667k | $1.3M |
| Two Sigma Advisers | Dec 2025 | 620k | $1.3M |
| Nomura Holdings | Dec 2025 | 225k | $455k |
| Graham Capital Management | Dec 2025 | 134k | $270k |
| Simplex Trading | Sep 2025 | 67k | $133k |
| Scientech Research | Dec 2025 | 30k | $61k |
| Quantbot Technologies | Dec 2025 | 19k | $38k |
| AQR Capital Management | Dec 2025 | 10k | $20k |
| SRS Capital Advisors | Dec 2025 | 1.6k | $3.2k |